CELVIVO ApS — Credit Rating and Financial Key Figures
CVR number: 35671099
Ørbækvej 264, 5220 Odense SØ
mail@celvivo.com
tel: 70228228
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | -2 543.55 | 2 656.32 | -2 493.50 | -1 489.03 | 1 462.59 |
Employee benefit expenses | -1 944.52 | -7 974.28 | -11 279.00 | -13 307.58 | -11 699.72 |
Total depreciation | -89.97 | - 625.73 | -5 269.26 | -6 653.30 | -7 095.35 |
EBIT | -4 578.04 | -5 943.69 | -19 041.76 | -21 449.91 | -17 332.49 |
Other financial income | 7.69 | 20.40 | -69.81 | - 161.89 | |
Other financial expenses | - 213.55 | -1 259.79 | -2 606.28 | -4 428.48 | -7 438.95 |
Net income from associates (fin.) | - 298.93 | -99.00 | -1 485.64 | ||
Pre-tax profit | -4 791.59 | -7 195.79 | -21 926.56 | -26 047.19 | -26 418.96 |
Income taxes | 1 189.23 | 2 468.89 | 5 849.07 | 5 772.86 | 5 520.00 |
Net earnings | -3 602.35 | -4 726.91 | -16 077.50 | -20 274.33 | -20 898.97 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Development expenditure | 9 190.68 | 19 072.34 | 22 203.77 | 21 458.53 | 18 927.06 |
Intangible rights | 853.73 | 1 212.71 | 1 619.57 | 2 346.07 | 2 289.26 |
Intangible assets total | 10 044.41 | 20 285.05 | 23 823.33 | 23 804.60 | 21 216.33 |
Buildings | 18.18 | 666.20 | 944.97 | 778.61 | 602.48 |
Machinery and equipment | 205.09 | 2 538.62 | 2 545.80 | 1 843.94 | 1 126.66 |
Advance payments and construction in progress | 1 413.87 | ||||
Tangible assets total | 1 637.14 | 3 204.82 | 3 490.77 | 2 622.55 | 1 729.14 |
Holdings in group member companies | 6.67 | ||||
Other receivables | 49.55 | 134.60 | 138.97 | 138.97 | 138.97 |
Investments total | 49.55 | 141.28 | 138.97 | 138.97 | 138.97 |
Long term receivables total | |||||
Semifinished products | 120.16 | 145.87 | 138.81 | 221.31 | |
Raw materials and consumables | 28.71 | 68.61 | 1 361.43 | 1 575.99 | 1 074.68 |
Finished products/goods | 667.15 | 1 103.83 | 746.51 | 2 328.93 | |
Inventories total | 28.71 | 855.93 | 2 611.13 | 2 461.31 | 3 624.93 |
Current trade debtors | 5.21 | 189.89 | 350.57 | 1 107.88 | 2 561.29 |
Current amounts owed by group member comp. | 1 259.96 | 546.89 | 954.99 | ||
Prepayments and accrued income | 113.11 | 165.50 | 127.32 | 290.80 | 233.31 |
Current other receivables | 1 135.31 | 1 360.36 | 298.51 | 609.84 | 403.74 |
Current deferred tax assets | 2 338.19 | 4 822.84 | 6 494.94 | 9 740.16 | 13 743.16 |
Short term receivables total | 3 591.83 | 6 538.59 | 8 531.30 | 12 295.56 | 17 896.48 |
Cash and bank deposits | 1 653.03 | 178.19 | 21.88 | 24.44 | 44.76 |
Cash and cash equivalents | 1 653.03 | 178.19 | 21.88 | 24.44 | 44.76 |
Balance sheet total (assets) | 17 004.66 | 31 203.85 | 38 617.39 | 41 347.43 | 44 650.60 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Share capital | 50.00 | 53.85 | 53.85 | 65.03 | 65.03 |
Share premium account | 380.75 | ||||
Other reserves | 7 168.73 | 14 876.42 | 17 328.37 | 16 744.32 | 18 914.99 |
Retained earnings | -4 749.11 | -16 059.16 | -22 847.82 | -15 397.61 | -37 793.25 |
Profit of the financial year | -3 602.35 | -4 726.91 | -16 077.50 | -20 274.33 | -20 898.97 |
Shareholders equity total | -1 132.73 | -5 475.04 | -21 543.11 | -18 862.59 | -39 712.19 |
Provisions | 1 253.41 | 1 312.17 | |||
Non-current accruals and deferred income | 1 300.03 | 800.24 | 354.88 | ||
Non-current other liabilities | 385.58 | 322.23 | |||
Non-current deferred tax liabilities | 322.23 | 340.51 | 351.07 | ||
Non-current liabilities total | 385.58 | 322.23 | 1 622.26 | 1 140.75 | 705.95 |
Current loans from credit institutions | 8 277.81 | 26 666.24 | 36 577.37 | ||
Current trade creditors | 2 128.85 | 1 233.76 | 1 119.19 | 2 386.52 | 1 588.77 |
Current owed to group member | 13 602.07 | 21 084.59 | 22 135.93 | ||
Other non-interest bearing current liabilities | 767.48 | 12 726.13 | 26 224.69 | 29 518.72 | 45 047.36 |
Accruals and deferred income | 780.62 | 497.79 | 443.35 | ||
Current liabilities total | 16 498.40 | 35 044.49 | 58 538.24 | 59 069.27 | 83 656.84 |
Balance sheet total (liabilities) | 17 004.66 | 31 203.85 | 38 617.39 | 41 347.43 | 44 650.60 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.